Last reviewed · How we verify

NCT05927103

Differences Between Coffee and Non-coffee Drinkers in the Gut Microbiome and Microbiota-Gut-Brain Axis

Completed Last updated 3 July 2023
What this trial tests

trial in Healthy in 62 participants. Completed in 18 January 2023.

Timeline
21 September 2021
Primary endpoint
18 January 2023
18 January 2023

Quick facts

Lead sponsorUniversity College Cork
StatusCompleted
Study typeOBSERVATIONAL
Enrollment62
Start date21 September 2021
Primary completion18 January 2023
Estimated completion18 January 2023
Sites1 location across Ireland

Conditions studied

Sponsor

University College Cork

Who can join

Adults 30 to 50, any sex, with Healthy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to investigate the potential of coffee to act as a prebiotic to alter gut microbiota and improve mood, memory and cognitive performance.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Habitual coffee intake shapes the gut microbiome and modifies host physiology and cognition.
    Boscaini S, Bastiaanssen TFS, Moloney GM, Bergamo F, et al · · 2026 · PMID 42014402 · DOI 10.1038/s41467-026-71264-8

Verify or expand the search:

Other recruiting trials for Healthy

Currently open trials in the same condition.

Other University College Cork trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05927103.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing